Literature DB >> 33338504

Breakthrough fungemia caused by Yarrowia lipolytica in a patient with gastric adenocarcinoma during echinocandin therapy.

Hsin-Yu Chi1, Ying-Shih Su2, Fu-Lun Chen2, Wen-Sen Lee3, Cheng-Hui Wang4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33338504     DOI： 10.1016/j.jinf.2020.12.008

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  3 in total

1.  Comparison of clinical characteristics and disease outcome of COVID-19 and seasonal influenza.

Authors:  Stefan Kluge; Julian Schulze Zur Wiesch; Thomas Theo Brehm; Marc van der Meirschen; Annette Hennigs; Kevin Roedl; Dominik Jarczak; Dominic Wichmann; Daniel Frings; Axel Nierhaus; Tim Oqueka; Walter Fiedler; Maximilian Christopeit; Christian Kraef; Alexander Schultze; Marc Lütgehetmann; Marylyn M Addo; Stefan Schmiedel
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

2.  Update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA 14: suitability of taxonomic units notified to EFSA until March 2021.

Authors:  Kostas Koutsoumanis; Ana Allende; Avelino Alvarez-Ordóñez; Declan Bolton; Sara Bover-Cid; Marianne Chemaly; Robert Davies; Alessandra De Cesare; Friederike Hilbert; Roland Lindqvist; Maarten Nauta; Luisa Peixe; Giuseppe Ru; Marion Simmons; Panagiotis Skandamis; Elisabetta Suffredini; Pier Sandro Cocconcelli; Pablo Salvador Fernández Escámez; Miguel Prieto-Maradona; Amparo Querol; Lolke Sijtsma; Juan Evaristo Suarez; Ingvar Sundh; Just Vlak; Fulvio Barizzone; Michaela Hempen; Lieve Herman
Journal:  EFSA J       Date:  2021-07-07

3.  A retrospective comparison between influenza and COVID-19-associated ARDS in a Croatian tertiary care center.

Authors:  Branimir Gjurašin; Marija Santini; Vladimir Krajinović; Neven Papić; Anita Atelj; Viktor Kotarski; Juraj Krznarić; Martina Vargović; Marko Kutleša
Journal:  Wien Klin Wochenschr       Date:  2020-11-20       Impact factor: 1.704
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.